-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 17, 2022, Deepcell announced the completion of a $73 million Series B financing
Unlike other cell analysis methods, Deepcell's technology is based on the morphological separation and collection of label-free single cells, maintaining cell integrity, which is critical for downstream biological analysis
Deepcell leverages AI-driven imaging and microfluidic technology platforms that can discover virtually any cell type as the basis for translational research, diagnostic assays, and therapeutic development
Image source: Deepcell's official website
Original link: https:// -Platform
https://